About Galixir

Galixir, founded in 2019, is dedicated to employing cutting-edge artificial intelligence (AI) technologies to accelerate drug research and development. By leveraging its AI algorithms and organically integrating computational chemistry and medicinal chemistry, Galixir optimizes preclinical R&D processes by providing high-quality drug candidates and cutting time and costs. This increases the overall probability of product launch. Collaborating with pharmaceutical companies and institutions globally, Galixir is advancing its drug discovery pipelines for multiple indications, and new drug candidates designed and screened by different modules of PyxirTM, the proprietary AIDD platform at Galixir, are proved to have high potency, surpassed the level of existing drugs while ensuring patentability.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology Research
location icon
Headquarter
Beijing, CN
description icon
Founded
2019
description icon
Keywords
Pharmaceuticals, Drug Discovery, Artificial Intelligence

Galixir Alternatives

Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more